Literature DB >> 31811020

PD-1 Expression during Acute Infection Is Repressed through an LSD1-Blimp-1 Axis.

Alexander P R Bally1,2, Dennis K Neeld1,2, Peiyuan Lu1,2, Parimal Majumder1,2, Yan Tang1,2, Benjamin G Barwick1,2, Qing Wang1,2, Jeremy M Boss3,4.   

Abstract

During prolonged exposure to Ags, such as chronic viral infections, sustained TCR signaling can result in T cell exhaustion mediated in part by expression of programmed cell death-1 (PD-1) encoded by the Pdcd1 gene. In this study, dynamic changes in histone H3K4 modifications at the Pdcd1 locus during ex vivo and in vivo activation of CD8 T cells suggested a potential role for the histone H3 lysine 4 demethylase LSD1 in regulating PD-1 expression. CD8 T cells lacking LSD1 expressed higher levels of Pdcd1 mRNA following ex vivo stimulation as well as increased surface levels of PD-1 during acute, but not chronic, infection with lymphocytic choriomeningitis virus (LCMV). Blimp-1, a known repressor of PD-1, recruited LSD1 to the Pdcd1 gene during acute, but not chronic, LCMV infection. Loss of DNA methylation at Pdcd1's promoter-proximal regulatory regions is highly correlated with its expression. However, following acute LCMV infection, in which PD-1 expression levels return to near baseline, LSD1-deficient CD8 T cells failed to remethylate the Pdcd1 locus to the levels of wild-type cells. Finally, in a murine melanoma model, the frequency of PD-1-expressing tumor-infiltrating LSD1-deficient CD8 T cells was greater than in wild type. Thus, LSD1 is recruited to the Pdcd1 locus by Blimp-1, downregulates PD-1 expression by facilitating the removal of activating histone marks, and is important for remethylation of the locus. Together, these data provide insight into the complex regulatory mechanisms governing T cell immunity and regulation of a critical T cell checkpoint gene.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31811020      PMCID: PMC6946872          DOI: 10.4049/jimmunol.1900601

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  NFATc1 regulates PD-1 expression upon T cell activation.

Authors:  Kenneth J Oestreich; Hyesuk Yoon; Rafi Ahmed; Jeremy M Boss
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

2.  Conserved Region C Functions To Regulate PD-1 Expression and Subsequent CD8 T Cell Memory.

Authors:  Alexander P R Bally; Yan Tang; Joshua T Lee; Benjamin G Barwick; Ryan Martinez; Brian D Evavold; Jeremy M Boss
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

3.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.

Authors:  Cheryl L Day; Daniel E Kaufmann; Photini Kiepiela; Julia A Brown; Eshia S Moodley; Sharon Reddy; Elizabeth W Mackey; Joseph D Miller; Alasdair J Leslie; Chantal DePierres; Zenele Mncube; Jaikumar Duraiswamy; Baogong Zhu; Quentin Eichbaum; Marcus Altfeld; E John Wherry; Hoosen M Coovadia; Philip J R Goulder; Paul Klenerman; Rafi Ahmed; Gordon J Freeman; Bruce D Walker
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

4.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

5.  The epigenetic landscape of T cell exhaustion.

Authors:  Debattama R Sen; James Kaminski; R Anthony Barnitz; Makoto Kurachi; Ulrike Gerdemann; Kathleen B Yates; Hsiao-Wei Tsao; Jernej Godec; Martin W LaFleur; Flavian D Brown; Pierre Tonnerre; Raymond T Chung; Damien C Tully; Todd M Allen; Nicole Frahm; Georg M Lauer; E John Wherry; Nir Yosef; W Nicholas Haining
Journal:  Science       Date:  2016-10-27       Impact factor: 47.728

6.  Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.

Authors:  A Prévost-Blondel; C Zimmermann; C Stemmer; P Kulmburg; F M Rosenthal; H Pircher
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

7.  SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation.

Authors:  Jens M Chemnitz; Richard V Parry; Kim E Nichols; Carl H June; James L Riley
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

8.  The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation.

Authors:  Jing Wang; Sarah Hevi; Julia K Kurash; Hong Lei; Frédérique Gay; Jeffrey Bajko; Hui Su; Weitao Sun; Hua Chang; Guoliang Xu; François Gaudet; En Li; Taiping Chen
Journal:  Nat Genet       Date:  2008-12-21       Impact factor: 38.330

9.  Activator protein 1 suppresses antitumor T-cell function via the induction of programmed death 1.

Authors:  Gang Xiao; Anqi Deng; Haifeng Liu; Gaoxiang Ge; Xiaolong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

10.  PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing.

Authors:  Ildikó Gyory; Jian Wu; György Fejér; Edward Seto; Kenneth L Wright
Journal:  Nat Immunol       Date:  2004-02-22       Impact factor: 25.606

View more
  7 in total

Review 1.  Transcriptional and epigenetic regulation of PD-1 expression.

Authors:  Zengde Chi; Yan Lu; Yinlong Yang; Bingqing Li; Peiyuan Lu
Journal:  Cell Mol Life Sci       Date:  2021-03-18       Impact factor: 9.261

Review 2.  Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases.

Authors:  Dongha Kim; Keun Il Kim; Sung Hee Baek
Journal:  J Biomed Sci       Date:  2021-06-04       Impact factor: 8.410

3.  Identification of a Sensitive Human Immunological Target of Aryl Hydrocarbon Receptor Activation: CD5+ Innate-Like B Cells.

Authors:  Lance K Blevins; Jiajun Zhou; Robert B Crawford; Norbert E Kaminski
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

4.  KDM1A Identified as a Potential Oncogenic Driver and Prognostic Biomarker via Multi-Omics Analysis.

Authors:  Lingyue Li; Yiyu Wang; Yuan Mou; Hao Wu; Ye Qin
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-12-09       Impact factor: 2.471

5.  Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade.

Authors:  Michael L Dixon; Lin Luo; Sadashib Ghosh; Jeffrey M Grimes; Jonathan D Leavenworth; Jianmei W Leavenworth
Journal:  Mol Cancer       Date:  2021-11-20       Impact factor: 27.401

Review 6.  Conserved and Unique Functions of Blimp1 in Immune Cells.

Authors:  Samantha Nadeau; Gislâine A Martins
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

7.  Inhibitory Molecules PD-1, CD73 and CD39 Are Expressed by CD8+ T Cells in a Tissue-Dependent Manner and Can Inhibit T Cell Responses to Stimulation.

Authors:  Corinne J Smith; Christopher M Snyder
Journal:  Front Immunol       Date:  2021-07-15       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.